Back to search

Article

Effective Gene Therapy for Metachromatic Leukodystrophy Achieved with Minimal Lentiviral Genomic Integrations

2024-03-14

Abstract excerpt

<h4>ABSTRACT</h4> Metachromatic leukodystrophy (MLD) is a fatal lysosomal storage disease (LSD) characterized by the deficient enzymatic activity of arylsulfatase A (ARSA). Combined autologous hematopoietic stem cell transplant (HSCT) with lentiviral (LV) based gene therapy has great potential to treat MLD. However, if enzyme production is inadequate, this could result in continued loss of motor function, implyin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1d618f1-1379-54c2-853e-98d1339b8c99
DOI
10.1101/2024.03.14.584404
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effective Gene Therapy for Metachromatic Leukodystrophy Achieved with Minimal Lentiviral Genomic IntegrationsDOI 10.1101/2024.03.14.584404
Select a neighboring publication to make it the new centre.